Clorox Hits 11-Year Low: Is the 5.7% Yield Worth the Risk?

Clorox (CLX) reported its Q3 fiscal 2026 earnings, sending its stock price to an 11-year low. The company highlighted strength in its cleaning and international segments but faced significant weakness in key categories like cat litter and food. Management revised its full-year organic sales guidance downward, now expecting a 9% decline compared to the prior forecast of a 5% to 9% drop.

The company also faces external pressures, including high oil prices, which are expected to shave $20-$25 million off quarterly gross profit. Aggressive discounting and promotional activity from competitors are squeezing sales, creating a tough environment for Clorox's premium brands.

Despite the challenges, CEO Linda Rendle expressed confidence in the resilience of the company's categories and its brands, noting that private-label market share did not increase this quarter. The company is betting on its recent $2.25 billion acquisition of GOJO Industries, the maker of Purell, to bolster its strongest segment: cleaning products.

Clorox expects the GOJO acquisition to add roughly 10% to its total revenue, with plans to improve the new division's margins over time through synergies. This move represents a strategic pivot to double down on what's working rather than spreading resources thin across underperforming categories.

For income investors, the plummeting stock price has pushed Clorox's dividend yield to a sky-high 5.7%. The valuation has also become compressed, with the stock trading at just 13.7 times fiscal 2027 earnings estimates, which appears cheap for a historically stable consumer staples name.

The company's future hinges on its ability to execute a successful turnaround. The GOJO acquisition is a critical test of management's strategy to focus on core strengths. If successful, it could stabilize sales and improve profitability. If not, it adds debt to a company already facing headwinds.

Clorox has developed a credibility problem with a history of overpromising and underdelivering on guidance. Until management can consistently meet its targets, the stock may remain under pressure despite its attractive yield and valuation.

This situation creates a classic contrarian investment dilemma. The stock is priced for continued failure, offering a high yield and low multiple. However, buying it requires a belief that management can break its bad habits, integrate GOJO effectively, and navigate a difficult consumer environment where trading down to value brands is a persistent threat.